Does RANIBIZUMAB Cause Metamorphopsia? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Metamorphopsia have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.7% of all adverse event reports for RANIBIZUMAB.
109
Reports of Metamorphopsia with RANIBIZUMAB
0.7%
of all RANIBIZUMAB reports
3
Deaths
10
Hospitalizations
How Dangerous Is Metamorphopsia From RANIBIZUMAB?
Of the 109 reports, 3 (2.8%) resulted in death, 10 (9.2%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Metamorphopsia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Metamorphopsia?
AFLIBERCEPT (123)
PREDNISONE (67)
BEVACIZUMAB (59)
BROLUCIZUMAB-DBLL (55)
ADALIMUMAB (33)
OCRIPLASMIN (31)
CYCLOSPORINE (29)
AMLODIPINE (25)
FINGOLIMOD (23)
RITUXIMAB (22)
Which RANIBIZUMAB Alternatives Have Lower Metamorphopsia Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE